Home›Companies›Reve Labs

Reve Labs Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 17, 2023·Suggest an edit

About Reve Labs

Reve Labs is a private company based in Brooklyn, New York, incorporated in 2022 in Delaware. It has reported $1,666,147 raised in six offerings on Form D since February 2023. Its chief executive is Aditya Bathla.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 17, 2023Mar 17, 2023$250,000target not set1$250KEquityRule 506(b)Form D ↗
Mar 16, 2023Mar 16, 2023$1,000,000target not set1$1.0MEquityRule 506(b)Form D ↗
Mar 14, 2023Mar 15, 2023$311,147target not set1$311KEquityRule 506(b)Form D ↗
Mar 10, 2023Mar 10, 2023amended Mar 15, 2023$50,000target not set1$50,000EquityRule 506(b)Form D/A ↗2 earlier filings
Feb 21, 2023Feb 27, 2023amended Mar 13, 2023$50,000target not set1$50,000EquityRule 504, Rule 506(b)Form D/A ↗1 earlier filing
Feb 10, 2023Feb 27, 2023amended Mar 13, 2023$5,000target not set1$5,000EquityRule 504, Rule 506(b)Form D/A ↗1 earlier filing
Total, six offerings$1,666,147

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Reve Labs's Form D filed Mar 17, 2023.

AB
Aditya Bathla
Chief Executive Officer and director
RS
Rashmi Sinha
Executive officer and director

Sources

  1. SECREVE LABS INC. Form D/A, filed Mar 13, 2023
  2. SECREVE LABS INC. Form D, filed Mar 10, 2023
  3. SECREVE LABS INC. Form D, filed Feb 27, 2023
  4. SECREVE LABS INC. Form D, filed Feb 27, 2023
  5. SECREVE LABS INC. filing history